Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 1,253 | 9,757 | 14,219 | 37,329 | 46,990 |
| Gross Profit | 1,253 | 9,757 | 14,219 | 37,329 | 46,990 |
| Operating Expenses | 221,437 | 143,546 | 104,503 | 67,032 | 82,917 |
| Operating Income | -220,184 | -133,789 | -90,284 | -29,703 | -35,927 |
| Other Income | 154 | -2,000 | -21,701 | -91,584 | 33,609 |
| Pre-tax Income | -220,030 | -135,789 | -111,985 | -121,287 | -2,318 |
| Net Income Continuous | -220,030 | -135,789 | -111,985 | -121,287 | -2,318 |
| Net Income | $-220,030 | $-135,789 | $-111,985 | $-121,287 | $-2,318 |
| EPS Basic Total Ops | -5.20 | -3.39 | -3.31 | -5.14 | -0.11 |
| EPS Basic Continuous Ops | -5.20 | -3.39 | -3.31 | -5.14 | -0.11 |
| EPS Diluted Total Ops | -5.20 | -3.39 | -3.31 | -5.14 | -0.11 |
| EPS Diluted Continuous Ops | -5.20 | -3.39 | -3.31 | -5.14 | -0.11 |
| EBITDA(a) | $-214,285 | $-127,667 | $-89,007 | $-28,178 | $-34,627 |